Invesco India Smallcap Fund
The scheme seeks to generate capital appreciation by investing predominantly in stocks of Small cap entities.
Growthvine rating: 4/5 — ranked #4 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹43.77 (as of 2026-10-23) |
|---|
| AUM | ₹16,175 Cr |
|---|
| Expense ratio | 1.44% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Taher Badshah |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 17.58% |
|---|
| Sharpe ratio | 0.75 |
|---|
| Standard deviation | 19.81% |
|---|
| Max drawdown | −37.67% |
|---|
| Alpha | 7.72 |
|---|
| Beta | 0.86 |
|---|
Over 5 years, captured 90.0% of NIFTY Smallcap 250's upside and 72.1% of its downside.
Market cap allocation
| Large cap | 15.1% |
|---|
| Mid cap | 15.8% |
|---|
| Small cap | 69.1% |
|---|
Concentration
| Top 5 holdings | 20.6% |
|---|
| Top 10 holdings | 34.2% |
|---|
| Total holdings | 74 |
|---|
| Index overlap | 16.6% |
|---|
| Active share | 83.4% |
|---|
Top holdings
- Sai Life Sciences Limited — 5.1%
- Triparty Repo — 4.5%
- Eternal Limited — 4.4%
- Aditya Infotech Limited — 4.0%
- Amber Enterprises India Limited — 3.7%
- Krishna Institute of Medical Sciences Limited — 3.4%
- InterGlobe Aviation Limited — 3.1%
- Max Healthcare Institute Limited — 3.0%
- Prestige Estates Projects Limited — 2.7%
- Paradeep Phosphates Limited — 2.4%
Top sectors
- Banking & Financial — 17.2%
- Retail — 13.3%
- Healthcare — 12.5%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 4.9% | Q2 | #16 of 34 |
| 2025 | −2.9% | Q2 | #13 of 30 |
| 2024 | 37.4% | Q1 (Top) | #4 of 28 |
| 2023 | 44.1% | Q2 | #11 of 24 |
| 2022 | −0.7% | Q3 | #13 of 22 |